Bildkälla: Stockfoto

Hansa Biopharma: Continues to make progress - Redeye

Redeye’s early key take-away is that Hansa’s European Ideflirix launch is well underway and that Hansa continues to make trial progress.

Redeye’s early key take-away is that Hansa’s European Ideflirix launch is well underway and that Hansa continues to make trial progress.
Börsvärldens nyhetsbrev
ANNONSER